Your browser doesn't support javascript.
loading
Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex.
Weir, Scott J; Dandawate, Prasad; Standing, David; Bhattacharyya, Sangita; Ramamoorthy, Prabhu; Rangarajan, Parthasarathy; Wood, Robyn; Brinker, Amanda E; Woolbright, Benjamin L; Tanol, Mehmet; Ham, Tammy; McCulloch, William; Dalton, Michael; Reed, Gregory A; Baltezor, Michael J; Jensen, Roy A; Taylor, John A; Anant, Shrikant.
Afiliación
  • Weir SJ; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA. sweir@kumc.edu.
  • Dandawate P; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA. sweir@kumc.edu.
  • Standing D; Institute for Advancing Medical Innovation, University of Kansas Medical Center, Kansas City, KS, USA. sweir@kumc.edu.
  • Bhattacharyya S; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Ramamoorthy P; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Rangarajan P; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Wood R; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Brinker AE; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Woolbright BL; Institute for Advancing Medical Innovation, University of Kansas Medical Center, Kansas City, KS, USA.
  • Tanol M; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Ham T; Institute for Advancing Medical Innovation, University of Kansas Medical Center, Kansas City, KS, USA.
  • McCulloch W; Department of Urology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Dalton M; Biotechnology Innovation and Optimization Center, University of Kansas, Lawrence, KS, USA.
  • Reed GA; School of Pharmacy, Istanbul Kemerburgaz University, Istanbul, Turkey.
  • Baltezor MJ; CicloMed LLC, Kansas City, MO, USA.
  • Jensen RA; Alba BioPharm Advisors Inc., Durham, NC, USA.
  • Taylor JA; The Gnomon Group, Carrboro, NC, USA.
  • Anant S; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.
Cell Death Dis ; 12(6): 562, 2021 05 31.
Article en En | MEDLINE | ID: mdl-34059639
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Transicionales / Secretasas de la Proteína Precursora del Amiloide / Ciclopirox / Antifúngicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Cell Death Dis Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Transicionales / Secretasas de la Proteína Precursora del Amiloide / Ciclopirox / Antifúngicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Cell Death Dis Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos